GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (NAS:NRC) » Definitions » Cyclically Adjusted PS Ratio

National Research (National Research) Cyclically Adjusted PS Ratio : 5.78 (As of Apr. 27, 2024)


View and export this data going back to 1997. Start your Free Trial

What is National Research Cyclically Adjusted PS Ratio?

As of today (2024-04-27), National Research's current share price is $33.81. National Research's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $5.85. National Research's Cyclically Adjusted PS Ratio for today is 5.78.

The historical rank and industry rank for National Research's Cyclically Adjusted PS Ratio or its related term are showing as below:

NRC' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.48   Med: 5.16   Max: 9.91
Current: 5.74

During the past years, National Research's highest Cyclically Adjusted PS Ratio was 9.91. The lowest was 1.48. And the median was 5.16.

NRC's Cyclically Adjusted PS Ratio is ranked worse than
88.22% of 331 companies
in the Healthcare Providers & Services industry
Industry Median: 1.18 vs NRC: 5.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

National Research's adjusted revenue per share data for the three months ended in Dec. 2023 was $1.548. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.85 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


National Research Cyclically Adjusted PS Ratio Historical Data

The historical data trend for National Research's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Cyclically Adjusted PS Ratio Chart

National Research Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.44 6.60 7.17 6.57 6.77

National Research Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.57 7.69 7.57 7.60 6.77

Competitive Comparison of National Research's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, National Research's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Research's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where National Research's Cyclically Adjusted PS Ratio falls into.



National Research Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

National Research's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=33.81/5.85
=5.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

National Research's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, National Research's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.548/129.4194*129.4194
=1.548

Current CPI (Dec. 2023) = 129.4194.

National Research Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1.055 99.695 1.370
201406 0.975 100.560 1.255
201409 0.964 100.428 1.242
201412 1.021 99.070 1.334
201503 1.070 99.621 1.390
201506 0.996 100.684 1.280
201509 1.032 100.392 1.330
201512 1.079 99.792 1.399
201603 1.135 100.470 1.462
201606 1.063 101.688 1.353
201609 1.098 101.861 1.395
201612 1.150 101.863 1.461
201703 1.220 102.862 1.535
201706 1.132 103.349 1.418
201709 1.142 104.136 1.419
201712 1.171 104.011 1.457
201803 1.218 105.290 1.497
201806 0.984 106.317 1.198
201809 1.176 106.507 1.429
201812 1.050 105.998 1.282
201903 1.234 107.251 1.489
201906 1.228 108.070 1.471
201909 1.261 108.329 1.506
201912 1.267 108.420 1.512
202003 1.316 108.902 1.564
202006 1.214 108.767 1.445
202009 1.302 109.815 1.534
202012 1.354 109.897 1.595
202103 1.382 111.754 1.600
202106 1.420 114.631 1.603
202109 1.472 115.734 1.646
202112 1.496 117.630 1.646
202203 1.514 121.301 1.615
202206 1.479 125.017 1.531
202209 1.517 125.227 1.568
202212 1.540 125.222 1.592
202303 1.474 127.348 1.498
202306 1.463 128.729 1.471
202309 1.537 129.860 1.532
202312 1.548 129.419 1.548

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


National Research  (NAS:NRC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


National Research Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of National Research's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research (National Research) Business Description

Traded in Other Exchanges
N/A
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Amandla Mk Trust 10 percent owner C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807
Common Property Trust 10 percent owner 709 PIER 2, LINCOLN NE 68528
Parul Bhandari director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Penny Ann Wheeler director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Donald M Berwick director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Jona S Raasch officer: Vice President and COO
Kevin R Karas officer: SVP Finance, CFO, Treas & Secy C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 10 percent owner C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801
Joann M Martin director 6221 ANDREW COURT, LINCOLN NE 68512
Helen Hrdy officer: Chief Growth Officer C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Steven D. Jackson officer: President C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
John N Nunnelly director P.O. BOX 2175, AMHERST MA 01004
Barbara Mowry director P.O. BOX 103115, DENVER CO 80250
Michael Hays director, 10 percent owner, officer: President and CEO C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508